Skip to content

This content is in French.

Metabolic syndrome associated with increased risk of kidney cancer

28 mai 2024

Metabolic syndrome associated with increased risk of kidney cancer
Kidney cancer accounts for over 13,000 cases per year in France, affecting men twice as much as women.
Metabolic syndrome is characterized by the presence of several physiological disorders, including hypertension, obesity, dyslipidemia, hypertriglyceridemia and hyperglycemia.

The researchers explored the link between metabolic syndrome and the risk of developing kidney cancer using data from the UK BioBank, comprising over 300,000 individuals aged 37 to 73.

Sign in to read the rest

Reserved for healthcare professionals, free registration.

Scientific reference

Wang L, Du H, Sheng C, Dai H, Chen K. Association between metabolic syndrome and kidney cancer risk: a prospective cohort study. Lipids Health Dis. 2024 May 17;23(1):142. doi: 10.1186/s12944-024-02138-5. PMID: 38760801; PMCID: PMC11100063.

View on PubMed